Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth of 17%. Consolidated Net Profit of ₹287 Crore, up 343% from -(₹118) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.48, up 343% from -(₹3.49) in the same quarter of the previous year.
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Related Post
- Reliance Industries Ltd Q3FY25; 12% rise in Profits
Reliance was founded by Dhirubhai Ambani and is now promoted and managed by his elder…
-
Raymond Ltd Q3FY25; 61% fall in Profits
Raymond Limited incorporated in 1925 is a diversified group with interests in Textile & Apparel…
-
RattanIndia Enterprises Ltd Q3FY25; 2% rise in Revenue
RattanIndia Enterprises Limited is the flagship company of Rattanindia Group. RattanIndia Enterprises Limited comprises of…